Related Experiment Videos
Effector pathways in immune mediated central nervous system demyelination
B C Kieseier1, M K Storch, J J Archelos
1Department of Neurology, Karl-Franzens Universität Graz, Austria. bc.kieseier@kfunigraz.ac.at
Current Opinion in Neurology
|September 28, 1999
Summary
Multiple sclerosis (MS) is traditionally viewed as a T-cell disease. However, emerging research highlights the significant role of antibodies and other molecules in MS pathogenesis and progression.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
Background:
- Multiple sclerosis (MS) is predominantly considered a T-cell mediated autoimmune disorder.
- Recent findings suggest a crucial involvement of antibodies in the disease process.
Purpose of the Study:
- To review the multifaceted immunological mechanisms implicated in multiple sclerosis.
- To highlight the evolving understanding of MS pathogenesis beyond T-cell responses.
Main Methods:
- Literature review of recent evidence on MS immunopathology.
- Analysis of the roles of various molecular mediators.
Main Results:
- Antibodies are increasingly recognized for their contribution to MS.
- Adhesion molecules, matrix metalloproteinases, chemokines, cytokines, nitric oxide, and oxygen metabolites are key players in MS.
- These factors are involved in disease amplification and effector phases.
Conclusions:
- The understanding of multiple sclerosis pathogenesis is expanding.
- Both T-cell responses and antibody-mediated mechanisms, alongside various molecular mediators, are critical in MS progression.